Cytokine-induced nitric-oxide-dependent apoptosis in mouse osteoblastic cells: Involvement of p38MAP kinase

Archives of Oral Biology

Volumn 51, Issue 11, 2006, Pages 1048-1053

  Kuzushima, Masatoshi ^a   Mogi, Makio ^a   Togari, Akifumi ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cytokine; Nitric oxide synthase; Osteoblasts; p38MAP kinase; SB203580

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYTOKINE; ENZYME INHIBITOR; FLAVONOID; GAMMA INTERFERON; IMIDAZOLE DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PYRIDINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; APOPTOSIS; ARTICLE; CELL LINE; DOSE RESPONSE; DRUG ANTAGONISM; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; MOUSE; OSTEOBLAST; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL LINE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLAVONOIDS; IMIDAZOLES; INTERFERON TYPE II; INTERLEUKIN-1BETA; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OSTEOBLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34047253789     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2006.05.004     Document Type: Article

References (24)

1. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
2. Tomkinson A., Gevers E.F., Wit J.M., Reeve J., and Noble B.S. The role of estrogen in the control of rat osteocyte apoptosis. J Bone Miner Res 13 (1998) 1243-1250
3. Yamamoto S., Mogi M., Kinpara K., et al. Anti-proliferative capsular-like polysaccharide antigen from Actinobacillus actinomycetemcomitans induces apoptotic cell death in mouse osteoblastic MC3T3-E1 cells. J Dent Res 78 (1999) 1230-1237
4. Morimoto Y., Morimoto H., Murata T., Kobayashi S., Ohba T., and Haneji T. Extracts of Actinobacillus actinomycetemcomitans induce apoptotic cell death in human osteoblastic MG63 cells. J Dent Res 78 (1999) 735-742
5. Mogi M., Otogoto J., Ota N., Inagaki H., Minami M., and Kojima K. Interleukin 1β, interleukin 6, β2-microglobulin, and transforming growth factor-α in gingival crevicular fluid from human periodontal disease. Arch Oral Biol 44 (1999) 535-539
6. Boch J.A., Wara-aswapati N., and Auron P.E. Interleukin 1 signal transduction-current concepts and relevance to periodontitis. J Dent Res 80 (2001) 400-407
7. Kirkham B. Interleukin-I, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis. Ann Rheum Dis 50 (1991) 395-400
8. Kendall H.K., Marshall R.I., and Bartold P.M. Nitric oxide and tissue destruction. Oral Dis 7 (2001) 2-10
9. Evans D.M., and Ralston S.H. Nitric oxide and bone. J Bone Miner Res 11 (1996) 300-305
10. Cobb M.H., and Goldsmith E.J. How MAP kinases are regulated. J Biol Chem 270 (1995) 14843-14846
11. Togari A., Arai M., Mogi M., Kondo A., and Nagatsu T. Coexpression of GTP cyclohydrolase I and inducible nitric oxide synthase mRNAs in mouse osteoblastic cells activated by proinflammatory cytokines. FEBS Lett 428 (1998) 212-216
12. Mogi M., Kinpara K., Kondo A., and Togari A. Involvement of nitric oxide and biopterin in proinflammatory cytokine-induced apoptotic cell death in mouse osteoblastic cell line MC3T3-E1. Biochem Pharmacol 58 (1999) 649-654
13. Mogi M., Kondo A., Kinpara K., and Togari A. Anti-apoptotic action of nerve growth factor in mouse osteoblastic cell line. Life Sci 67 (2000) 1197-1206
14. Ozeki N., Mogi M., Nakamura H., and Togari A. Differential expression of the Fas-Fas ligand system on cytokine-induced apoptotic cell death in mouse osteoblastic cells. Arch Oral Biol 47 (2002) 511-517
15. Damoulis P.D., and Hauschka P.V. Cytokines induce nitric oxide production in mouse osteoblasts. Biochem Biophys Res Commun 201 (1994) 924-931
16. Damoulis P.D., and Hauschka P.V. Nitric oxide acts in conjunction with proinflammatory cytokines to promote cell death in osteoblasts. J Bone Miner Res 12 (1997) 412-422
17. Hukkanen M., Hughes F.J., Buttery L.D., et al. Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology 136 (1995) 5445-5453
18. Jilka R.L., Weinstein R.S., Bellido T., Parfitt A.M., and Manolagas S.C. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res 13 (1998) 793-802
19. Da Silva J., Pierrat B., Mary J.L., and Lesslauer W. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J Biol Chem 272 (1997) 28373-28380
20. Badger A.M., Cook M.N., Lark M.W., et al. SB203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes. J Immunol 161 (1998) 467-473
21. Zambon J.J. Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol 12 (1985) 1-20
22. Slots J., and Genco R.J. Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival, and tissue destruction. J Dent Res 63 (1984) 412-421
23. Genco R.J. Current view of risk factors for periodontal diseases. J Periodontol 67 (1996) 1041-1049
24. Aoshiba K., Yasui S., Hayashi M., Tamaoki J., and Nagai A. Role of p38-mitogen-activated protein kinase in spontaneous apoptosis of human neutrophils. J Immunol 162 (1999) 1692-1700